Beleave Expands Medi-Green Network with the Announcement of

New Post Public Reply Private Reply Replies (2) Message Board
Jerseyfish
269
Beleave Expands Medi-Green Network with the Announcement of Two New Stores
[PR Newswire]
PR Newswire•August 7, 2018

TORONTO, Aug. 7, 2018 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company" is excited to announce the opening of two new Medi-Green stores which will be located in London, Ontario and Montreal, Quebec.

Medi-Green is a wholly-owned subsidiary of Beleave Inc. and was acquired by the company earlier this year. The two stores mark the first new locations since the acquisition.

"First, we're thrilled to be opening our new location in Montreal, which will be our first store in Quebec, as we feel there is tremendous opportunity in that market," said Beleave CEO, Andrew Wnek. "Also, with the addition of our new London location, we're coming through on our commitment to provide the residents of Ontario with quality and accessible medicinal cannabis in a safe and trusted environment. We have aggressive plans for expanding the Medi-Green brand and these two new stores are just the beginning."

The Montreal location will be the first to open in mid-September. At 1530 sq. ft. it will be located at 4123 St. Denis street in the heart of the popular Plateau Mont-Royal district. Long-recognized as a hub for art, food, and culture, the shops on St. Denis are an integral part of the community, close to the subway, and are a destination for tourists and locals alike. Employee training and onboarding for that location is already underway.

In late-September, Medi-Green will be opening the London store. With approximately 1500 sq. ft. of space, it will be located at 211 Dundas Street. Employee training and onboarding will begin on September 3rd.

"With the new stores, Medi-Green's superior customer service and respected expertise will be available to even more Canadians," said Beleave CFO, Bojan Krasic. "As the distribution and point of sale landscape evolves, we will continue to invest in additional locations, employee training, and community outreach to be advantageously positioned for new opportunities as they arise."

ABOUT BELEAVE INC.
Beleave is a biotech company who's wholly-owned subsidiary Beleave Kannabis Corp. is licensed to cultivate and sell medical cannabis and produce cannabis oils and extracts pursuant to Health Canada's Access to Cannabis for Medical Purpose Relations. Beleave has developed a network of medical cannabis clinics under the Medi-Green banner and has applied for various patents to broaden its strong research focused foundation.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Castle Biosciences Unveils Key Data on TissueCypher at ACG

Updated Category News Views 289

New Insights from Castle Biosciences at Annual Meeting Castle Biosciences, Inc. (NASDAQ: CSTL) recently highlighted groundbreaking research at a prestigious conference, showcasing its innovative TissueCypher Barrett's Esophagus test. This test provides critical risk insights that go beyond traditional pathology, influencing clinical management for early intervention in...

Continue Reading
Ben Foster Takes Charge as Chair of Rural Broadband Board

Updated Category News Views 97

Announcement of Ben Foster's Chair Appointment In a significant development for rural connectivity, Ben Foster, President and CEO of Twin Valley, has been appointed as the chair of the National Rural Broadband Association (NTCA). As a leader of Kansas' largest independently owned broadband and communications company, Foster's new role marks an important step for improving...

Continue Reading
Interoil's Bond Payment Restructuring Proposal Explained

Updated Category News Views 260

Interoil's Bond Payment Restructuring Proposal Interoil Exploration and Production ASA (the "Company") has initiated a process with Nordic Trustee AS to gather bondholders for a written resolution. This action concerns the senior secured callable bonds identified by ISIN NO 001 0729908 (the "Bonds"). Purpose of the Written Resolution The primary goal of this resolution is...

Continue Reading
DoubleLine Income Solutions Fund Announces Upcoming Distribution

Updated Category News Views 103

DoubleLine Income Solutions Fund Declares Distribution The DoubleLine Income Solutions Fund (the "Fund"), recognized under the symbol DSL on the New York Stock Exchange, has announced a forthcoming distribution of $0.11 per share. It’s important for investors to stay informed about the timing and details of these distributions. Distribution Overview This distribution...

Continue Reading
Interoil Reports October Production Growth and Updates

Updated Category News Views 118

Key Production Metrics and Overview Interoil Exploration and Production ASA has recently released its production metrics, showcasing a notable improvement in operational output for October. The total operated production in October averaged 2,239 barrels of oil equivalent per day (boepd), representing an increase of 157 boepd from the previous month. This positive trend...

Continue Reading